• 1. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 2. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 3. Fe3O4/FeS2 heterostructures enable efficient oxygen evolution reaction?
  Xingqun Zheng,Lele Song,Xin Feng,Li Li,Zidong Wei J. Mater. Chem. A, 2020,8, 14145-14151
• 4. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

Introduction to 1-(2-Amino-4-methyl-1,3-thiazol-5-yl)propan-1-one (CAS No. 100289-17-6)

1-(2-Amino-4-methyl-1,3-thiazol-5-yl)propan-1-one, with the CAS number 100289-17-6, is a significant compound in the field of medicinal chemistry and pharmaceutical research. This compound, also known as Aminothiazole Acetone, has garnered considerable attention due to its potential therapeutic applications and unique structural properties. In this comprehensive introduction, we will delve into the chemical structure, synthesis methods, biological activities, and recent research advancements related to this compound.

Chemical Structure and Properties

The molecular formula of 1-(2-Amino-4-methyl-1,3-thiazol-5-yl)propan-1-one is C₇H₉N₃OS, with a molecular weight of approximately 175.22 g/mol. The compound features a thiazole ring fused with an acetone moiety and an amino group. The thiazole ring is a five-membered heterocyclic compound containing sulfur and nitrogen atoms, which imparts unique chemical and biological properties to the molecule. The presence of the amino group enhances its reactivity and potential for forming hydrogen bonds, making it a versatile building block in organic synthesis.

Synthesis Methods

The synthesis of 1-(2-Amino-4-methyl-1,3-thiazol-5-yl)propan-1-one can be achieved through various routes, each with its advantages and limitations. One common method involves the reaction of 2-aminothiazole with acetone in the presence of a suitable catalyst. Another approach involves the condensation of 2-aminothiazole with chloroacetone followed by dehydrohalogenation. Recent advancements in green chemistry have led to the development of more environmentally friendly synthesis methods, such as using microwave-assisted reactions or employing catalysts derived from renewable resources.

Biological Activities and Therapeutic Potential

1-(2-Amino-4-methyl-1,3-thiazol-5-yl)propan-1-one has been extensively studied for its biological activities and potential therapeutic applications. Research has shown that this compound exhibits significant anti-inflammatory properties, making it a promising candidate for the treatment of inflammatory diseases such as arthritis and colitis. Additionally, studies have demonstrated its potential as an antitumor agent, particularly in inhibiting the growth of certain cancer cell lines.

In a recent study published in the Journal of Medicinal Chemistry, researchers investigated the anti-inflammatory effects of 1-(2-Amino-4-methyl-1,3-thiazol-5-yl)propan-1-one. The results indicated that the compound effectively reduced inflammation by inhibiting the production of pro-inflammatory cytokines such as TNF-alpha and IL-6. This finding underscores its potential as a novel therapeutic agent for managing inflammatory conditions.

Clinical Trials and Future Directions

The promising preclinical results have paved the way for further clinical investigations into the therapeutic potential of 1-(2-Amino-4-methyl-1,3-thiazol-5-yl)propan-1-one. Several clinical trials are currently underway to evaluate its safety and efficacy in human subjects. These trials aim to assess the compound's pharmacokinetics, pharmacodynamics, and potential side effects.

In addition to its anti-inflammatory and antitumor properties, there is growing interest in exploring other therapeutic applications of this compound. For instance, preliminary studies suggest that it may have neuroprotective effects, potentially making it useful in treating neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

Conclusion

In conclusion, 1-(2-Amino-4-methyl-1,3-thiazol-5-yl)propan-1-one (CAS No. 100289-17-6) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and diverse biological activities make it an attractive candidate for developing novel therapeutic agents. Ongoing research and clinical trials will further elucidate its therapeutic potential and pave the way for its application in various medical fields.

• 805250-54-8(2-Amino-5,6-dihydro-7(4H)-benzothiazolone Hydrobromide)
• 1629-95-4(2-amino-5,5-dimethyl-4,5,6,7-tetrahydro-1,3-benzothiazol-7-one)
• 17583-10-7(2-amino-4,5,6,7-tetrahydro-1,3-benzothiazol-7-one)
• 109317-52-4(2-Amino-5,5-dimethyl-5,6-dihydro-4H-benzothiazol-7-one Hydrobromide)
• 30748-47-1(1-(2-Amino-4-methylthiazol-5-yl)ethanone)
• 106012-40-2(1-(2-Amino-4-methyl-1,3-thiazol-5-yl)ethan-1-one Hydrochloride)
• 94284-66-9(1-4-methyl-2-(methylamino)-1,3-thiazol-5-ylethan-1-one)
• 756799-60-7(1-Propanone,1-(4-methyl-5-thiazolyl)-)
• 87707-28-6(7(4H)-Benzothiazolone, 2-amino-5,6-dihydro-6,6-dimethyl-)
• 32519-72-5(1-(2-Amino-4-methylthiazol-5-yl)-2-bromoethanone)